237 related articles for article (PubMed ID: 16773693)
1. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.
Gockel I; Dirksen K; Messow CM; Junginger T
World J Gastroenterol; 2006 Jun; 12(23):3746-50. PubMed ID: 16773693
[TBL] [Abstract][Full Text] [Related]
2. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
[TBL] [Abstract][Full Text] [Related]
3. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma.
Nozoe T; Saeki H; Sugimachi K
Am J Surg; 2001 Aug; 182(2):197-201. PubMed ID: 11574097
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
5. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
7. Preoperative elevation of serum C-reactive protein as an indicator of poor prognosis for early-stage esophageal squamous cell carcinoma.
Song ZB; Lin BC; Li B; He CX; Zhang BB; Shao L; Zhang YP
Kaohsiung J Med Sci; 2013 Dec; 29(12):662-6. PubMed ID: 24296054
[TBL] [Abstract][Full Text] [Related]
8. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
[TBL] [Abstract][Full Text] [Related]
9. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
[TBL] [Abstract][Full Text] [Related]
10. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).
Lukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Siewko M; Szmitkowski M
J Clin Lab Anal; 2012 Feb; 26(2):73-81. PubMed ID: 22467322
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma.
Suzuki T; Shimada H; Nanami T; Oshima Y; Yajima S; Washizawa N; Kaneko H
Int J Clin Oncol; 2017 Jun; 22(3):461-468. PubMed ID: 28064398
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
14. Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma.
Meng YQ; Cao X; Wen ZS; Liu QW; Tan ZH; Duan H; Ma GW; Lin P
Dis Esophagus; 2014; 27(7):670-7. PubMed ID: 24033446
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis.
Huang W; Wu L; Liu X; Long H; Rong T; Ma G
J Cardiothorac Surg; 2019 Sep; 14(1):167. PubMed ID: 31533862
[TBL] [Abstract][Full Text] [Related]
17. Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer.
Ibuki Y; Hamai Y; Hihara J; Emi M; Taomoto J; Furukawa T; Yamakita I; Kurokawa T; Okada M
World J Surg; 2017 Jun; 41(6):1558-1565. PubMed ID: 28120093
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of transhiatal esophagectomy for esophageal carcinoma. A multivariate analysis of prognostic factors.
Gertsch P; Vauthey JN; Lustenberger AA; Friedlander-Klar H
Cancer; 1993 Oct; 72(8):2312-9. PubMed ID: 8402444
[TBL] [Abstract][Full Text] [Related]
19. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
[TBL] [Abstract][Full Text] [Related]
20. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
